Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 423 participants.

Also called NCT06935591

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 423 participants (planned count) (from the registry)
Sponsor
Vektor Medical (from the registry)
Registry
  • NCT NCT06935591
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06935591. Randomized; no masking; primary purpose treatment. Start 2025-06-27 (actual); primary completion 2027-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
Acronym
IMPRoVED-AF
Condition
Atrial Fibrillation (AF)
Intervention (Procedure)
Pulmonary Vein Isolation
Intervention (Device)
vMap® + Pulmonary Vein Isolation
Lead sponsor
Vektor Medical (class: industry)
Collaborator
Veranex Switzerland SA (class: industry)
Collaborator
Veranex (class: not stated)

Record details

Record id
cardio:ct-nct06935591
Content hash
ea9161d45f79e34db5fe370d6168991067c57fd51dccf892b3c3a478cad25e77